A new approach to a common gastric infection.

Consumers are increasingly looking for natural ways to stay healthy. Pylopass™ from Novozymes is a natural way to help manage the presence of Heliobactor pylori in the stomach. Pylopass™ contains a selected strain of L.reuteri that is spray dried and uses as a dietary supplement.

Contact us below if you want to hear more:


Your details:

* Required


Novozymes Berlin GmbH
Gustav-Meyer-Allee 25
Geb.12, Etage 3
13355 Berlin
E-Mail: pylopass@novozymes.com

General Manager
Klaus Pellengahr, PhD

Commercial Registry
Amtsgericht Charlottenburg: HRB 82025
USt-ID-Nr.: DE158699815


This website is an overview for professionals of published scientific information on Pylopass™ and published scientific information on clinical and nutritional trials with Pylopass™. No claims are made herein for any particular consumer product, and any use of these statements is the sole responsibility of the user based on his / her independent evaluation. The republication of the statements made herein is prohibited. It is always important to ensure that final communications to the consumer on food and food supplement products containing Pylopass™ comply with the applicable regulations in the regions / countries where the products are marketed.

The recommended use for Pylopass™ is as a nutrient or dietary supplement. The intended use of products containing Pylopass™ may be subject to different laws and regulations. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Pylopass™ is not intended for use to diagnose, treat, cure or prevent any disease. The information contained herein is believed to be correct and corresponds to the latest state of scientific and technical knowledge. However, no warranty is made, either expressed or implied, regarding its accuracy or the results to be obtained from the use of such information and no warranty is expressed or implied concerning the use of these products. The buyer assumes all risks of use and / or handling. No statement is intended or should be construed as a recommendation to infringe any existing patent.